0000000000499282
AUTHOR
J. Liang
Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019
Background: Sustainable Development Goal 3.2 has targeted elimination of preventable child mortality, reduction of neonatal death to less than 12 per 1000 livebirths, and reduction of death of children younger than 5 years to less than 25 per 1000 livebirths, for each country by 2030. To understand current rates, recent trends, and potential trajectories of child mortality for the next decade, we present the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 findings for all-cause mortality and cause-specific mortality in children younger than 5 years of age, with multiple scenarios for child mortality in 2030 that include the consideration of potential effects of COVID-…
β-delayed neutron emission of r-process nuclei at the N = 82 shell closure
This experiment was performed at RI Beam Factory operated by RIKEN Nishina Center and CNS, University of Tokyo. O.H, T.D, P.J.W, C.G.B, C.J.G and D.K would like to thank STFC, UK for support. This research was sponsored in part by the Office of Nuclear Physics, U.S. Department of Energy under Award No. DE-FG02-96ER40983 (UTK) and DEAC05-00OR22725 (ORNL), and by the National Nuclear Security Administration under the Stewardship Science Academic Alliances program through DOE Award No. DENA0002132. This work was supported by National Science Foundation under Grants No. PHY-1430152 (JINA Center for the Evolution of the Elements), No. PHY-1565546 (NSCL), and No. PHY-1714153 (Central Michigan Uni…
Nonsurgical treatments for primary liver carcinoma in elderly patients: a 12-year retrospective study
Introduction: Cancer is a leading cause of death. 70 percent of cases develop over the age of 65. Although a few patients with metastatic cancer are potentially resectable for cure (particularly those with isolated metastases), treatment for most patients is palliative and generally consists of systemic chemotherapy asoociated to target therapy. Objectives: To evaluate efficacy, safety and outcome of the addition of bevacizumab to chemotherapy in advanced cancer in elderly patients, a prospective study was carried on the last four years at Gonesse Hospital Group. Methods: Patients older than 65year with advanced metastatic (Stage IV) cancer (fourteen colorectal carcinoma, five breast carcin…
The global forest above-ground biomass pool for 2010 estimated from high-resolution satellite observations
Funding Information: We are thankful to the GlobBiomass project team and Frank Martin Seifert (ESA) for valuable suggestions and stimulating scientific discussions. We are thankful to Takeo Tadono (JAXA EORC), Masato Hayashi, (JAXA EORC), Kazufumi Kobayashi (RESTEC), Åke Rosenqvist (soloEO), and Josef Kellndorfer (EBD) for support with the use and interpretation of the ALOS PALSAR mosaics. Support by the CCI Land Cover project team, in particular Sophie Bontemps (UCL), is greatly acknowledged. The help from Martin Jung (MPI-BGC) in feature selection and Ulrich Weber (MPI-BGC) for data processing for the GSV-to-AGB conversions is greatly acknowledged. Forest inventory data for the validation…
Compilation and Evaluation of Beta-Delayed Neutron Emission Probabilities and Half-Lives for Z > 28 Precursors
Abstract We present a compilation and evaluation of experimental β-delayed neutron emission probabilities (Pn) and half-lives (T1/2) for known or potential β-delayed neutron precursors with atomic number Z > 28 (73Cu–233Fr). This article includes the recommended values of both of these quantities, together with a compilation of experimental measurements when available. Some notable cases, as well as proposed standards for β-delayed neutron measurements are also discussed. Evaluated data has also been compared to systematics using three different approaches. The literature cut-off date for this work is August 15, 2020.